Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Miller Website

Robert William Miller, Ph.D.

Selected Publications

1)  Miller RW, Raubitschek AA, Harrington FS, van de Geijn J, Ovadia J, Glatstein E.
An isocentric chair for the simulation and treatment of radiation therapy patients.
Int. J. Radiat. Oncol. Biol. Phys. 21: 469-73, 1991.
[Journal]
2)  Miller R.
A new approach to handling blocked photon fields in radiotherapy treatment planning.
Ann Arbor, MI: UMI Press; 1998. [Book]
3)  Ranchoux G, Magne S, Bouvet JP, Ferdinand P.
Remote Optical Fiber Dosimetry.
Nucl. Instr. Meth. of Phys.B. 184: 55-67, 2001.
[Journal]
4)  Huston A, Justus B, Falkenstein P, Miller R, Ning H, Altemus R.
Optically stimulated luminescent glass optical fiber dosimeter.
Radiat Prot Dosimetry. 101: 23-6, 2002.
[Journal]
5)  Zhuge Y, Ciesielski KC, Udupa JK, Miller RW.
GPU-based relative fuzzy connectedness image segmentation.
Med Phys. 40: 011903, 2013.
[Journal]
6)  Simone CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL.
Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.
Radiother Oncol. 101: 376-82, 2011.
[Journal]
7)  Li G, Xie H, Ning H, Citrin D, Kaushal A, Camphausen K, Miller RW.
Correction of motion-induced misalignment in co-registered PET/CT and MRI (T1/T2/FLAIR) head images for stereotactic radiosurgery.
J Appl Clin Med Phys. 12: 3306, 2011.
[Journal]
8)  Zhuge Y, Cao Y, Udupa JK, Miller RW.
Parallel fuzzy connected image segmentation on GPU.
Med Phys. 38: 4365-71, 2011.
[Journal]
9)  Fearon T, Xie H, Cheng JY, Ning H, Zhuge Y, Miller RW.
Patient-specific CT dosimetry calculation: a feasibility study.
J Appl Clin Med Phys. 12: 3589, 2011.
[Journal]
10)  Sharma RK, Schabowsky RH, Srivastava AK, Elpek KG, Madireddi S, Zhao H, Zhong Z, Miller RW, Macleod KJ, Yolcu ES, Shirwan H.
4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.
Cancer Res. 70: 3945-54, 2010.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 7/13/2014.